Shanghai Abelzeta Ltd.

This is an early-stage trial testing the safety of a new type of personalized immune cell therapy called C-CAR031. It is for adults with an advanced form of squamous cell lung cancer that has a specific marker (GPC3+) and has stopped responding to up to three prior treatments. Th…

This is the first human study of an experimental cell therapy called A-CAR032 for men with advanced prostate cancer that has spread and stopped responding to standard hormone treatments. The trial will test the safety of different doses and see if the therapy can shrink tumors. I…

This study is testing a new, experimental CAR-T cell therapy called Prizlon-cel in adults whose large B-cell lymphoma has come back or hasn't responded to standard treatments. The therapy is designed to attack cancer cells using two targets (CD19 and CD20). The first part of the …

This study is testing a new type of personalized cell therapy called C-CAR031 for adults with advanced liver cancer that has come back or stopped responding to standard treatments. Doctors will take a patient's own immune cells, modify them in a lab to better target the cancer, a…